Sentence: Phase 2 study of irinotecan and paclitaxel in patients with recurrent or refractory small cell lung cancer .
Drug combination annotation:
[{'class': 'POS', 'spans': ['irinotecan', 'paclitaxel'], 'is_context_needed': True}]